May 21-23, 2025 — Bioer Technology made a strong impression at KIHE 2025 – the 30th Kazakhstan International Healthcare Exhibition, held at the Atakent Kazakhstan Center for Business Cooperation (KCDS) in Almaty. As the largest and most established healthcare exhibition in Central Asia, KIHE has, for three decades, served as a key platform connecting medical professionals, pharmaceutical experts, and healthcare leaders across the region and beyond.
At this landmark event, Bioer Technology showcased its advanced molecular diagnostic and laboratory solutions, including:
GenePure Pro Nucleic Acid Purification System
QuantGene 9600 Fluorescent Quantitative Detection System
LineGene Mini S Fluorescent Quantitative Detection System
CentriDx™ Automated Nucleic Acid Analyzer
GeneExplorer Thermal Cycler
A broad portfolio of nucleic acid detection assays and laboratory consumables
These products reflect Bioer’s commitment to empowering laboratories with high-performance, reliable, and user-friendly tools for molecular testing—supporting applications in clinical diagnostics, disease surveillance, scientific research, and more.
With over 20 years of expertise in the molecular field, Bioer Technology has remained dedicated to innovation and excellence. The company continues to focus on automation, miniaturization, digitization, and integration, striving to simplify workflows and enhance efficiency for users worldwide.
Participation in KIHE 2025 not only deepened Bioer's engagement with the Central Asian market but also reinforced its vision for global growth. In the years ahead, Bioer Technology will continue expanding its international presence, delivering advanced molecular diagnostic solutions to partners and laboratories not only in Central Asia, but across the world.